| Literature DB >> 33420834 |
Nozomi Matsumura1, Naoki Goda2,3, Konomi Yashige3, Masashi Kitagawa4, Tatsuya Yamazaki5, Sumihito Nobusawa5, Hideaki Yokoo5.
Abstract
Desmoplastic myxoid tumor (DMT), SMARCB1-mutant is a recently proposed brain tumor that occurs in the pineal region of adults. This tumor is characterized by desmoplastic stroma and various degrees of myxoid matrix. Tumor cells with low-grade morphology show polyphenotypic immunoreactivity, and rhabdoid cells are rare. We herein present a case with some uncommon features such as no myxoid stroma and slightly elevated proliferating activity. To date, knowledge on the variety of SMARCB1/INI1-deficient tumors of the central nervous system is gradually increasing, encompassing highly aggressive to slow-growing varieties. DMT, SMARCB1-mutant seems to be relatively benign, but careful attention is necessary because SMARCB1/INI1 deficiency is generally a genetic signature of concern.Entities:
Keywords: Atypical teratoid/rhabdoid tumor; DMT, SMARCB1-mutant; Myxoid stroma; Pineal region; SMARCB1-mutant
Year: 2021 PMID: 33420834 DOI: 10.1007/s00428-020-02978-3
Source DB: PubMed Journal: Virchows Arch ISSN: 0945-6317 Impact factor: 4.064